Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by YOSHIKI NISHIZAWA
Synergistic Enhancement by 12-O-Tetradecanoylphorbol- 13-Acetate and Dibutyryl cAM P of 1.alpha.,25-Dihydroxyvitamin D3 Action in Human Promyelocytic Leukemic HL-60 Cells.
Endocrine Journal
Endocrinology
Metabolism
Diabetes
Related publications
Enhancement of 1α,25-Dihydroxyvitamin D3-Induced Differentiation of Human Leukaemia HL-60 Cells Into Monocytes by Parthenolideviainhibition of NF-κB Activity
British Journal of Pharmacology
Pharmacology
1 Alpha,25-Dihydroxyvitamin D3 Suppresses Proliferation and Immunoglobulin Production by Normal Human Peripheral Blood Mononuclear Cells.
Journal of Clinical Investigation
Medicine
Interaction of 1.alpha.,24-Dihydroxyvitamin D3 With the Chick Intestinal 1.alpha.,25-Dihydroxyvitamin D3 Receptor System.
Journal of Nutritional Science and Vitaminology
Medicine
Nutrition
Dietetics
Changes in Glycosaminoglycan Synthesis During the Differentiation of HL-60 Cells Induced by 12-O-Tetra-Decanoylphorbol-13-Acetate.
Journal of Pharmacobio-Dynamics
Regulation of Metallothionein Gene Expression by 1 Alpha,25-Dihydroxyvitamin D3 in Cultured Cells and in Mice.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Radioligand Receptor Assay for 25-Hydroxyvitamin D2/D3 and 1 Alpha, 25-Dihydroxyvitamin D2/D3.
Journal of Clinical Investigation
Medicine
Differential Activation of Dibutyryl cAMP-differentiated HL-60 Human Leukemia Cells by Chemoattractants
Biochemical Pharmacology
Biochemistry
Pharmacology
Rapamycin Is a Potent Inhibitor of Skin Tumor Promotion by 12-O-Tetradecanoylphorbol-13-Acetate
Cancer Prevention Research
Medicine
Cancer Research
Oncology
Induction of Apoptosis in HL-60 Human Promyelocytic Leukemia Cells by Adenosine A3Receptor Agonists
Biochemical and Biophysical Research Communications
Biochemistry
Cell Biology
Molecular Biology
Biophysics
